Who is sponsoring NCT06232785?

NCT06232785 is sponsored by Second Hospital of Jilin University.

What condition does NCT06232785 study?

NCT06232785 studies Motion Sickness, Postoperative Nausea and Vomiting, Ibuprofen.

What drugs are being tested in NCT06232785?

Interventions: Ibuprofen, sufentanil.

What is the status of NCT06232785?

NCT06232785 is currently COMPLETED.

Last reviewed 2024-01-31 · How we verify

Gynecologic Endoscopic Surgery of Female Motion Sickness Patients

NCT06232785 PHASE4 COMPLETED

The goal of this clinical trial is to compare the analgesic effect of sufentanil and ibuprofen and the incidence of vomiting, and to choose better postoperative analgesic drugs for motion sickness patients.in describe participant population. The main questions it aims to answer are: * Whether this anesthesia method can meet the analgesic needs of gynecological laparoscopic surgery. * Whether this anesthesia method can reduce the incidence of nausea and vomiting in patients with motion sickness after gynecological laparoscopic surgery. Participants will use target-controlled infusion anesthesia combined with 0.8g ibuprofen injection. Researchers will compare with use of target-controlled infusion combined with sufentanil to see if the incidence of nausea and vomiting is higher.

Details

Lead sponsor	Second Hospital of Jilin University
Phase	PHASE4
Status	COMPLETED
Enrolment	66
Start date	Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Motion Sickness
Postoperative Nausea and Vomiting
Ibuprofen

Interventions

Ibuprofen
sufentanil

Countries

China